1-9 of 9
Hyam Levitsky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Phase II Trial of Interferon (IFN)/GM-CSF Versus K562/GM-CSF Vaccination in Chronic Phase CML Patients on Frontline Tyrosine Kinase Inhibitor (TKI) Therapy: Potential of IFN to Enhance Molecular Remissions

Jonathan Allen Webster, MD, Anna Ferguson, BSN, RN, Christopher Gocke, MD, Richard J Jones, MD, Hyam Levitsky, MD, B. Douglas Smith, MD
Journal: Blood
Blood (2016) 128 (22): 3088.
https://doi.org/10.1182/blood.V128.22.3088.3088
Published: 2016
Journal Articles

Tumor Antigen Vaccination of Donors to Augment Graft-Versus-Tumor Effects after Allogeneic Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide

Han-Hsuan Fu, PhD, Jie Wang, MD, Jie Fu, MS, Richard J Jones, MD, Hyam Levitsky, MD, Ephraim J. Fuchs, MD
Journal: Blood
Blood (2016) 128 (22): 499.
https://doi.org/10.1182/blood.V128.22.499.499
Published: 2016
Journal Articles

Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells

Christopher G. Kanakry, Allan D. Hess, Christopher D. Gocke, Christopher Thoburn, Ferdynand Kos, Christian Meyer, Janet Briel, Leo Luznik, B. Douglas Smith, Hyam Levitsky, Judith E. Karp
Journal: Blood
Blood (2011) 117 (2): 608–617.
https://doi.org/10.1182/blood-2010-04-277939
Published: 2011
Journal Articles

Immune Recovery after Timed Sequential Therapy in Acute Myelogenous Leukemia: Discordant Recovery of Naïve T Lymphocytes and Antigen Driven Regulatory T Cells.

Allan D. Hess, PhD, Christian Meyer, Christopher Thoburn, Ferdynand Kos, Christopher Gocke, Hyam Levitsky, Judith Karp
Journal: Blood
Blood (2008) 112 (11): 947.
https://doi.org/10.1182/blood.V112.11.947.947
Published: 2008
Journal Articles

Identification of New Alloantigen-Reactive CD8 + Cytotoxic and Suppressor T Cell Subpopulations.

Osnat Bohana-Kashtan, PhD, Hyam Levitsky, MD, Curt I. Civin, MD
Journal: Blood
Blood (2007) 110 (11): 3229.
https://doi.org/10.1182/blood.V110.11.3229.3229
Published: 2007
Journal Articles

Escape from Suppression: Tumor-Specific Effector Cells Out-Compete Regulatory T Cells Following Stem Cell Transplantation.

Paria Mirmonsef, MS, Gladys Tan, Ph.D., Gang Zhou, Ph.D., Tricia Pyhel, D.O., Ivan M. Borrello, M.D., Hyam Levitsky, M.D.
Journal: Blood
Blood (2006) 108 (11): 69.
https://doi.org/10.1182/blood.V108.11.69.69
Published: 2006
Journal Articles

In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity

Pedro Horna, Alex Cuenca, Fengdong Cheng, Jason Brayer, Hong-Wei Wang, Ivan Borrello, Hyam Levitsky, Eduardo M. Sotomayor
Journal: Blood
Blood (2006) 107 (7): 2871–2878.
https://doi.org/10.1182/blood-2005-07-3014
Published: 2006
Journal Articles

Characterization of Vaccine Site and Cellular Infiltrate in Subjects with Chronic Myeloid Leukemia (CML) Receiving K562/GM-CSF Vaccination in Combination with Imatinib Mesylate with or without Topical Imiquimod.

Christina Y. Chia, MD, B. Douglas Smith, MD, Yvette Kasamon, MD, Carole B. Miller, MD, Mary E. Brummet, MS, Lora Bankova, MD, Jeanne Kowalski, PhD, Barbara Biedrzycki, MSN, Kristen Hege, Lisa A. Beck, MD, Hyam Levitsky, MD
Journal: Blood
Blood (2005) 106 (11): 2399.
https://doi.org/10.1182/blood.V106.11.2399.2399
Published: 2005
Journal Articles

T cells to go

Hyam Levitsky
Journal: Blood
Blood (2001) 98 (3): 503.
https://doi.org/10.1182/blood.V98.3.503
Published: 2001